Showing results (81-90 of 427) with videos related to

Sort By:
Pageof 43
Clinical Breast Cancer|October 28, 2004
Effect of cardiac dysfunction on treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancerDebu Tripathy, Andrew Seidman, Deborah Keefe, et al.
Oncology (Williston Park, N.Y.)|March 1, 1997
Paclitaxel for breast cancer: the Memorial Sloan-Kettering Cancer Center experienceA D Seidman, C A Hudis, G Raptis, et al.
Seminars in Oncology|October 1, 1995
Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancerA D Seidman, C A Hudis, D Fennelly, et al.
The Canadian Journal of Oncology|December 1, 1995
High-dose chemotherapy of breast cancerJ Crown, G Raptis, N Hamilton, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|November 9, 2010
Bone scans, bisphosphonates, and a lack of acute changes within the mandiblePatrick G Morris, Clifford Hudis, Jorge Carrasquillo, et al.
Breast Cancer Research and Treatment|June 4, 2017
The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosisGulisa Turashvili, Edi Brogi, Monica Morrow, et al.
BMC Cancer|January 7, 2018
Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-upGulisa Turashvili, Edi Brogi, Monica Morrow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2014
Building a rapid learning health care system for oncology: the regulatory framework of CancerLinQRichard L Schilsky, Dina L Michels, Amy H Kearbey, et al.
Cancer|November 24, 2004
Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based seriesMark Robson, Tiffany Svahn, Beryl McCormick, et al.
Cancer|September 1, 1991
A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinomaD Kelsen, C Hudis, D Niedzwiecki, et al.
Pageof 43